Literature DB >> 8625444

Azoxymethane enhances ligand-induced activation of EGF receptor tyrosine kinase in the colonic mucosa of rats.

E Malecka-Panas1, S E Fligiel, N K Relan, S Dutta, A P Majumdar.   

Abstract

Recent observations suggest that transforming growth factor alpha (TGF-alpha), which binds to the epidermal growth factor (EGF) receptor (EGFR), may induce neoplastic growth of the colonic mucosa through an autocrine mechanism. To assess the functional role of TGF-alpha in colonic carcinogenesis the present investigation examines the changes in TGF-alpha-and EGF-induced activation of intrinsic tyrosine kinase (Tyr-k) activity of EGFR in the colonic mucosa of rats after administration of the colonic carcinogen azoxymethane (AOM; 20 mg/kg body wt). Five days after a single injection of AOM to 4- to 5-month old rats proliferative activity (as assessed by 5-bromo-2'-deoxyuridine immunoreactivity) in the colonic mucosa was increased by approximately 700% over the corresponding saline-injected controls. This was accompanied by: (i) a marked rise in autophosphorylation of a number of mucosal proteins, including one with a M(r) of 170 kDa, a molecular mass that corresponds to EGFR; (ii) a 110-130% increase in basal EGFR Tyr-k activity. Despite this rise in basal EGFR Tyr-k activity, exposure of isolated colonocytes or detergent-solubilized colonic mucosa from AOM-treated animals to either 1 x 10(-8) M TGF-alpha or EGF caused a further 90-160% increase in EGFR Tyr-k activity over the corresponding basal levels. In contrast, bombesin produced no apparent change in EGFR Tyr-k activity. We conclude that increased ligand-induced activation of EGFR Tyr-k may be an important event for development of the hyperproliferative state associated with induction of colorectal neoplasia.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8625444     DOI: 10.1093/carcin/17.2.233

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  5 in total

1.  Expression of proliferating cell nuclear antigen in polyps from large intestine.

Authors:  Yu-Qin Luo; Lian-Sheng Ma; Yi-Ling Zhao; Kai-Chun Wu; Bo-Rong Pan; Xue-Yong Zhang
Journal:  World J Gastroenterol       Date:  1999-04       Impact factor: 5.742

2.  Gastric mucosal proliferative and total tyrosine kinases activities increase in Helicobacter pylori-induced chronic gastritis.

Authors:  Justyna Kotynia; Radzislaw Kordek; Alicja Kozlowska; Ewa Malecka-Panas
Journal:  Int J Gastrointest Cancer       Date:  2005

3.  Dietary calcium supplementation enhances efficacy but also toxicity of EGFR inhibitor therapy for colon cancer.

Authors:  Erica S Rinella; Eric D Bankaitis; David W Threadgill
Journal:  Cancer Biol Ther       Date:  2012-02-01       Impact factor: 4.742

4.  Efficacy of EGFR inhibition is modulated by model, sex, genetic background and diet: implications for preclinical cancer prevention and therapy trials.

Authors:  Erica S Rinella; David W Threadgill
Journal:  PLoS One       Date:  2012-06-25       Impact factor: 3.240

Review 5.  The epidermal growth factor receptor as a target for gastrointestinal cancer therapy.

Authors:  Karen L Tedesco; A Craig Lockhart; Jordan D Berlin
Journal:  Curr Treat Options Oncol       Date:  2004-10
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.